Another significant prospective study evaluated 25 patients with oily skin that received intradermal forehead injections of botulinum toxin and revealed significantly lower sebum production per a sebumeter at one week and one, two, and three months after the injections.[62] Additionally, 91 percent of subjects were satisfied with intradermal botulinum toxin as a treatment for their oily skin.[62] In terms of the mechanism of action, botulinum toxin cleaves proteins involved in vesicle fusion with the plasma membrane of the presynaptic neurons axon terminal
It was also slightly better than 25mg/day of amitriptyline (tricyclic antidepressant, commonly prescribed for migraine prevention).[ref] Related articles: Migraines, genetics, root causes Inflammation and Obesity: Low-grade inflammation is associated with obesity
[1] Wegovy is now the worlds first and only GLP-1 receptor agonist to treat MASH and the and the second treatment ever authorized by the FDA for MASH
PubMed - Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation: Details angiogenesis mechanisms
In children, it is also indicated for the treatment of Lennox-Gastaut syndrome